Avstera Therapeutics
PrivateLast Round
Accelerator
Oct 13, 2023
Total Funding Raised
$9.55M
Momentum Score
50 /100
Company Overview
Avstera Therapeutics is a biotechnology company that develops therapies to address the significant needs of advanced cancer patients with limited or no treatment options.
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avstera Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Avstera Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Oct 13, 2023 | ||||
| Series A | Oct 2, 2023 | ||||
| Seed | Nov 9, 2022 |
Avstera Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| University of Pennsylvania | Seed |
| Togo Ventures | Series A |
| Backswing Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 18, 2026
Monthly visitors grew 110% MoM, reaching 1.7K.
- Jul 2, 2025
Monthly visitors increased 2623% from 30 to 817.
Avstera Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Avstera Therapeutics's valuation, stock price, and market status.
